KROS
Keros Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:52:36 AM EST
11.83USD-1.417%(-0.17)16,400
KROS Financials
In Q3 FY 2026 (ended ), Keros Therapeutics, Inc. Common Stock (KROS) reported revenue of $40.01M, net income of $14.15M, operating cash flow of $3.39M, and assets of $307.37M (filed ).
Loading business breakdowns…